-
< Back to Bill Search
-
Senate Committee References (3)
- Health Policy (HP)
- Appropriations Committee on Health and Human Services (AHS)
- Rules (RC)
-
Related Bills (2)
Bill Number Subject Filed By Last Action and Location Relationship Learn more about bill relationships H 697 (c1) by Health & Human Services Committee
Drug Prices and Coverage
Last Action: 3/2/2026 H Bill added to Special Order Calendar (3/5/2026)Compare S 1760 (c2) by Brodeur
Health Care Coverage
Last Action: 3/4/2026 S CS/CS by Appropriations read 1st timeCompare -
Citations - Statute (10)
The page numbers, when listed, for citations are constantly under review. The journals or printed bills of the respective chambers should be consulted as the official documents of the Legislature.
The links for the page numbers are formatted to open the bill text PDF directly to the page containing the citation. However, if your browser is set to open PDFs in a new window, as is often the case with 64-bit browsers, the bill text will open to the first page.381.02036 Page 3 (pdf) 465.0244 Information disclosure. Page 4 (pdf) 499.044 Page 5 (pdf) 626.8825 Pharmacy benefit manager transparency and accountability. Page 6 (pdf) 626.8827 Pharmacy benefit manager prohibited practices. Page 10 (pdf) 627.4231 Page 11 (pdf) 627.42398 Page 12 (pdf) 627.6699 Employee Health Care Access Act. Page 14 (pdf) 641.30 Construction and relationship to other laws. Page 16 (pdf) 641.31 Health maintenance contracts. Page 16 (pdf) -
Bill History
S = Senate, H = House
1/6/2026 S • Filed
1/12/2026 S • Referred to Health Policy; Appropriations Committee on Health and Human Services; Rules
1/13/2026 S • Introduced
SB 1158: Drug Prices and Coverage
GENERAL BILL by Grall
Drug Prices and Coverage; Requiring the Agency for Health Care Administration to contract with an entity to designate reference price source countries and analyze certain data; requiring the agency to publish annually prescription drug reference prices; prohibiting pharmacies from charging cash-paying customers more than the reference prices for prescribed drugs and biological products; requiring prescription drug manufacturer permitholders to annually report to the agency international drug price data beginning on a specified date; requiring certain health insurers to limit covered prescription drug reimbursement to reference prices, etc.
Current Bill Version Posted: 1/6/2026 09:10 AM